Bright light therapy for gut inflammation in Crohn’s or colitis
Part of Digestive system clinical trials.
This trial studies whether daily bright light can improve gut barrier “leakiness” and reduce inflammation in adults with Crohn’s disease or ulcerative colitis. It compares bright light versus dim light in a crossover design, meaning you may receive both.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Crohn’s disease or ulcerative colitis confirmed by biopsy
- You are 18 years or older
- You currently have signs of active gut inflammation (from stool/blood tests) or high fatigue
- You have been on a stable Crohn’s/colitis medication plan for at least 12 weeks
- You can give informed consent and understand study procedures
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether morning light therapy can help reduce inflammation in people with ulcerative colitis. It may be an option if you have active inflammation and can attend light sessions.
This Phase 1 trial tests a new drug called LMT503 in adults to learn its safety, tolerability, and how the body handles it. If you qualify, you may receive the study medicine in a controlled research setting with regular checkups and blood/heart monitoring.
This trial tests a new infrared light treatment to see if it can reduce inflammation and symptoms in people with Crohn's disease. It's for those who have active disease despite current treatments or who are not on therapy.
This trial compares two methods to spot pre-cancerous changes during routine colonoscopy in people with inflammatory bowel disease (IBD). One method uses a special light filter (TXI) and the other uses a blue dye spray (chromoendoscopy) to see if TXI works as well or better.
This study tests whether combining a specific diet with biologic medicines can reduce active inflammation and symptoms of Crohn’s disease. It may help people who still have active disease in the bowel despite prior care.
This trial tests new therapies for people with moderate to severe Crohn's disease or ulcerative colitis. It may help if your standard treatments aren't working well enough.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.